Comparison of two methods of block for upper abdominal cancer pain-Ultrasound versus image guided technique in terms of quality of life and pain scores
- Conditions
- Health Condition 1: null- Stage 4 upper abdominal cancer patients with pain and NRS more than 4
- Registration Number
- CTRI/2018/05/014120
- Lead Sponsor
- Dr Sushma Bhatnagar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Diagnosed case of upper abdominal cancer (lower third of the esophagus, stomach, pancreas, gall bladder, biliary tract)
2.Age 18-80 years
3.Either gender
4.Stage 4 (spread of cancer to distant organs like liver, lungs, brain or bones)
5.Patients in need of opioids for upper abdominal pain
6.NRS > 4
7.Feasible CPB on recent CT scan
1.Patient on anticoagulation therapy
2.Local or intra-abdominal infection
3.Sepsis
4.Huge ascites
5.Patients with bowel obstruction
6.Patients with opioid addiction or history of drug abuse
7.Patients refusal to participate in the study
8.Clotting abnormalities
9.Psychiatric illness affecting cooperation
10.Previous history of neurolytic block
11.Unstable cardiovascular and respiratory diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analgesic efficacy in terms of opioid consumption and quality of life after 2 and 4 weeks of the blockTimepoint: Analgesic efficacy in terms of opioid consumption and quality of life after 2 and 4 weeks of the block
- Secondary Outcome Measures
Name Time Method Comparing efficacy of both the techniques in terms of <br/ ><br>1.NRS pain scores <br/ ><br>2.Side effects of block techniques <br/ ><br>3.Patient satisfaction <br/ ><br>4.Patient discomfort during the procedure <br/ ><br>5.Duration of complete and effective analgesia <br/ ><br> <br/ ><br>Timepoint: Analgesic efficacy in terms of opioid consumption and quality of life after 2 and 4 weeks of the block